Literature DB >> 12709304

Dopamine thioethers: formation in brain and neurotoxicity.

Kathleen S. Montine1, Kathrin R. Sidell, Jing Zhang, Thomas J. Montine.   

Abstract

Dopamine (DA) oxidation is proposed to be a significant contributor to some forms of neurodegeneration, although the mechanisms are not fully resolved. Recent results from in vitro and in vivo models have suggested that some products of oxidized DA metabolized along the mercapturic acid pathway (MAP) may contribute to dopaminergic neurodegeneration. Here we review recent findings on the localization of MAP enzymes in human brain, as well as the concentration and neurotoxicity of their DA thioether products.

Entities:  

Year:  2002        PMID: 12709304     DOI: 10.1080/1029842021000045435

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  35 in total

1.  Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease.

Authors:  E D Louis; L A Klatka; Y Liu; S Fahn
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

2.  Molecular characterization of a novel gamma-glutamyl transpeptidase homologue found in rat brain.

Authors:  T Yamaguchi; N Takei; K Araki; K Ishii; T Nagano; T Ichikawa; T Kumanishi; H Nawa
Journal:  J Biochem       Date:  2000-07       Impact factor: 3.387

Review 3.  Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies.

Authors:  I G McKeith; E K Perry; R H Perry
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 4.  Transition metals as catalysts of "autoxidation" reactions.

Authors:  D M Miller; G R Buettner; S D Aust
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

5.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

6.  On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase.

Authors:  J Segura-Aguilar; C Lind
Journal:  Chem Biol Interact       Date:  1989       Impact factor: 5.192

7.  Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

Authors:  J P Spencer; P Jenner; S E Daniel; A J Lees; D C Marsden; B Halliwell
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

Review 8.  Toxicology of quinone-thioethers.

Authors:  T J Monks; S S Lau
Journal:  Crit Rev Toxicol       Date:  1992       Impact factor: 5.635

9.  The adrenochrome hypothesis of schizophrenia revisited.

Authors:  John Smythies
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

10.  Cysteine S-conjugate N-acetyltransferase from rat kidney microsomes.

Authors:  M W Duffel; W B Jakoby
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

View more
  2 in total

1.  Z-ligustilide potentiates the cytotoxicity of dopamine in rat dopaminergic PC12 cells.

Authors:  Hongyi Qi; Jia Zhao; Yifan Han; Allan S Y Lau; Jianhui Rong
Journal:  Neurotox Res       Date:  2012-03-27       Impact factor: 3.911

2.  Effects of Commonly Used Pesticides in China on the Mitochondria and Ubiquitin-Proteasome System in Parkinson's Disease.

Authors:  Tingting Chen; Jieqiong Tan; Zhengqing Wan; Yongyi Zou; Henok Kessete Afewerky; Zhuohua Zhang; Tongmei Zhang
Journal:  Int J Mol Sci       Date:  2017-11-23       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.